Was the Confluent (CFLT) share sale made under a Rule 10b5-1 plan?

Yes. The 23,100 Class A shares were sold pursuant to a Rule 10b5-1 trading plan that was adopted on June 10, 2025.

Confluent director exercises options, sells 23,100 Class A shares

Q: What insider transaction did a Confluent (CFLT) director report?

A Confluent director exercised stock options to acquire 23,100 Class B common shares at $2.24 each, which converted into Class A shares, and then sold 23,100 Class A shares on December 10, 2025.

Q: How many Confluent (CFLT) Class A shares were sold and at what prices?

The director sold 23,100 shares of Confluent Class A common stock at prices ranging from $30.00 to $30.02.

Q: What are the details of the Confluent director’s stock options involved in this filing?

The director exercised a fully vested stock option for 23,100 shares with an exercise price of $2.24 per share, expiring on October 21, 2028, with the underlying security listed as Class B common stock.

Confluent, Inc. director reported equity transactions on December 10, 2025.

Filing Impact

(High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Confluent, Inc. director reported equity transactions on December 10, 2025. The director exercised stock options to buy 23,100 shares of Class B common stock at $2.24 per share, which converted into an equal number of Class A shares. The director then sold 23,100 Class A shares at prices ranging from $30.00 to $30.02 under a Rule 10b5-1 trading plan adopted June 10, 2025. After these trades, the director held 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Narkhede Neha

Role Director

Sold 23,100 shs ($693K)

Approx. gross sale proceeds $693K

Approx. exercise cost $52K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	23,100	$0.00	$0.00
Exercise	Class B Common Stock	23,100	$0.00	$0.00
Conversion	Class B Common Stock	23,100	$0.00	$0.00
Conversion	Class A Common Stock	23,100	$0.00	$0.00
Sale	Class A Common Stock	23,100	$30.00	$693K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 457,502 contracts (Direct); Class B Common Stock — 1,083,729 contracts (Direct); Class A Common Stock — 28,549 shares (Direct); Class A Common Stock — 1,787 shares (Indirect, By Trust)

Footnotes (4)

F1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
F2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.
F3. The shares were sold at prices ranging from $30.00 to $30.02. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4. Fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did a Confluent (CFLT) director report?

A Confluent director exercised stock options to acquire 23,100 Class B common shares at $2.24 each, which converted into Class A shares, and then sold 23,100 Class A shares on December 10, 2025.

How many Confluent (CFLT) Class A shares were sold and at what prices?

The director sold 23,100 shares of Confluent Class A common stock at prices ranging from $30.00 to $30.02.

How many Confluent (CFLT) Class A shares does the director own after the transaction?

After the reported transactions, the director beneficially owns 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.

What are the details of the Confluent director’s stock options involved in this filing?

The director exercised a fully vested stock option for 23,100 shares with an exercise price of $2.24 per share, expiring on October 21, 2028, with the underlying security listed as Class B common stock.

How do Confluent (CFLT) Class B shares relate to Class A shares in this report?

Each share of Confluent Class B common stock held by the director is convertible into one share of Class A common stock, including automatic conversion upon sale or transfer and optional conversion at any time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 12/12/2025 - 06:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Narkhede Neha

(Last)

(First)

(Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW

94041

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	12/10/2025		C		23,100	A	⁽¹⁾	51,649	D
Class A Common Stock	12/10/2025		S		23,100⁽²⁾	D	$30⁽³⁾	28,549	D
Class A Common Stock								1,787	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$2.24	12/10/2025		M			23,100	⁽⁴⁾	10/21/2028	Class B Common Stock	23,100	$0	457,502	D
Class B Common Stock	⁽¹⁾	12/10/2025		M		23,100		⁽¹⁾	⁽¹⁾	Class A Common Stock	23,100	$0	1,106,829	D
Class B Common Stock	⁽¹⁾	12/10/2025		C			23,100	⁽¹⁾	⁽¹⁾	Class A Common Stock	23,100	$0	1,083,729	D

Explanation of Responses:

1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.

3. The shares were sold at prices ranging from $30.00 to $30.02. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Fully vested.

	/s/ Weilyn Wood, Attorney-in-Fact	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR